Graig Suvannavejh Score: 28
Analyst at
Mizuho Securities,
Goldman Sachs
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+23.5%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
47%
27 W / 31 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
55%
22 W / 18 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
5%
2 W / 38 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
5%
2 W / 38 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
44%
21 W / 27 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
46%
26 W / 30 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
50%
1 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jul 20, 2026 |
Amylyx Pharmaceuticals Inc
AMLX
|
BUY |
$24.00
Est. +35%
|
$17.75 | $18.87 |
Pending
|
$17.70
-0.3%
|
| Jun 16, 2026 |
Insmed Inc
INSM
|
BUY |
$192.00
Est. +97%
|
$97.46 | $119.54 |
Pending
|
$106.64
+9.4%
|
| May 26, 2026 |
Belite Bio Inc - ADR
BLTE
|
BUY |
$215.00
Est. +57%
|
$137.30 | $161.43 |
Pending
|
$157.14
+14.5%
|
| May 22, 2026 |
Corbus Pharmaceuticals Holdings Inc
CRBP
|
BUY |
$44.00
Est. +259%
|
$12.27 | $12.88 |
Pending
|
$8.84
-28.0%
|
| Apr 28, 2026 |
Amylyx Pharmaceuticals Inc
AMLX
|
BUY |
$21.00
Est. +24%
|
$16.88 | $19.15 |
Pending
|
$17.70
+4.9%
|
| Feb 19, 2026 |
Insmed Inc
INSM
|
BUY |
$211.00
Est. +40%
|
$151.11 | $167.37 |
Pending
|
$106.64
-29.4%
|
| Feb 19, 2026 |
Immatics N.V
IMTX
|
BUY |
$25.00
Est. +151%
|
$9.95 | $11.94 |
Pending
|
$9.17
-7.8%
|
| Feb 19, 2026 |
Belite Bio Inc - ADR
BLTE
|
BUY |
$223.00
Est. +28%
|
$173.91 | $192.28 |
Pending
|
$157.14
-9.6%
|
| Feb 09, 2026 |
Immix Biopharma Inc
IMMX
|
BUY |
$14.00
Est. +108%
|
$6.74 | $12.14 |
Pending
|
$9.41
+39.6%
|
| Jan 29, 2026 |
Corvus Pharmaceuticals Inc
CRVS
|
BUY |
$30.00
Est. +46%
|
$20.54 | $22.34 |
Pending
|
$13.99
-31.9%
|
| Jan 05, 2026 |
Neumora Therapeutics Inc.
NMRA
|
BUY |
$6.00
Est. +249%
|
$1.72 | $3.65 |
Pending
|
$1.54
-10.5%
|
| Dec 31, 2025 |
Axsome Therapeutics Inc
AXSM
|
BUY |
$217.00
Est. +19%
|
$182.86 | $260.19 |
Target Met
|
$239.62
+31.0%
|
| Dec 18, 2025 |
Insmed Inc
INSM
|
BUY |
$212.00
Est. +26%
|
$167.71 | $186.19 |
Pending
|
$106.64
-36.4%
|
| Dec 02, 2025 |
Belite Bio Inc - ADR
BLTE
|
BUY |
$194.00
Est. +26%
|
$154.02 | $192.94 |
Bullseye Hit (±1%)
|
$157.14
+2.0%
|
| Dec 01, 2025 |
Insmed Inc
INSM
|
BUY |
$256.00
Est. +23%
|
$207.77 | $212.75 |
Pending
|
$106.64
-48.7%
|
| Nov 28, 2025 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$33.00
Est. +15%
|
$28.75 | $53.18 |
Target Met
|
$52.95
+84.2%
|
| Nov 03, 2025 |
Apellis Pharmaceuticals Inc
APLS
|
SELL |
$19.00
Est. +12%
|
$21.47 | $16.83 (Low) |
Target Met
|
$41.03
-91.1%
|
| Oct 29, 2025 |
Insmed Inc
INSM
|
BUY |
$196.00
Est. +17%
|
$166.97 | $212.75 |
Target Met
|
$106.64
-36.1%
|
| Oct 29, 2025 |
Immatics N.V
IMTX
|
BUY |
$19.00
Est. +83%
|
$10.36 | $12.40 |
Pending
|
$9.17
-11.5%
|
| Oct 29, 2025 |
EyePoint Pharmaceuticals Inc
EYPT
|
BUY |
$33.00
Est. +169%
|
$12.25 | $19.01 |
Pending
|
$12.66
+3.3%
|
| Oct 22, 2025 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$9.00
Est. +11%
|
$8.12 | $53.18 |
Target Met
|
$52.95
+552.1%
|
| Oct 21, 2025 |
Verastem Inc
VSTM
|
BUY |
$14.00
Est. +72%
|
$8.12 | $10.83 |
Pending
|
$5.89
-27.5%
|
| Oct 20, 2025 |
EyePoint Pharmaceuticals Inc
EYPT
|
BUY |
$28.00
Est. +141%
|
$11.63 | $19.01 |
Pending
|
$12.66
+8.9%
|
| Sep 19, 2025 |
Athira Pharma Inc
ATHA
|
BUY |
$4.00
Est. +4%
|
$3.83 | $8.35 |
Target Met
|
$6.75
+76.2%
|
| May 20, 2025 |
Corvus Pharmaceuticals Inc
CRVS
|
BUY |
$11.00
Est. +199%
|
$3.68 | $26.95 |
Target Met
|
$13.99
+280.2%
|
| Mar 27, 2025 |
Axsome Therapeutics Inc
AXSM
|
BUY |
$216.00
Est. +77%
|
$121.77 | $191.50 |
Miss
|
$239.62
+96.8%
|
| Feb 03, 2025 |
Axsome Therapeutics Inc
AXSM
|
BUY |
$137.00
Est. +28%
|
$107.43 | $191.50 |
Target Met
|
$239.62
+123.0%
|
| Nov 18, 2024 |
Autolus Therapeutics plc - ADR
AUTL
|
BUY |
$7.60
Est. +151%
|
$3.03 | $3.45 |
Miss
|
$1.44
-52.5%
|
| Oct 22, 2024 |
Corvus Pharmaceuticals Inc
CRVS
|
BUY |
$12.00
Est. +59%
|
$7.56 | $10.00 |
Miss
|
$13.99
+85.1%
|
| Oct 10, 2024 |
Harmony Biosciences Holdings Inc
HRMY
|
BUY |
$52.00
Est. +55%
|
$33.60 | $41.61 |
Miss
|
$34.86
+3.7%
|
| Sep 25, 2024 |
Ideaya Biosciences Inc
IDYA
|
BUY |
$55.00
Est. +75%
|
$31.37 | $32.67 |
Miss
|
$35.00
+11.6%
|
| Sep 23, 2024 |
BioXcel Therapeutics Inc
BTAI
|
BUY |
$1.00
Est. +69%
|
$0.59 | $13.28 |
Target Met
|
$0.88
+49.1%
|
| Sep 20, 2024 |
Apellis Pharmaceuticals Inc
APLS
|
BUY |
$39.00
Est. +6%
|
$36.73 | $35.72 |
Miss
|
$41.03
+11.7%
|
| Sep 20, 2024 |
Adverum Biotechnologies Inc
ADVM
|
BUY |
$20.00
Est. +167%
|
$7.50 | $8.56 |
Miss
|
$4.36
-41.9%
|
| Sep 16, 2024 |
Apellis Pharmaceuticals Inc
APLS
|
BUY |
$42.00
Est. +12%
|
$37.62 | $37.84 |
Miss
|
$41.03
+9.1%
|
| Sep 13, 2024 |
Corbus Pharmaceuticals Holdings Inc
CRBP
|
BUY |
$74.00
Est. +43%
|
$51.58 | $56.93 |
Miss
|
$8.84
-82.9%
|
| Sep 12, 2024 |
Immunocore Holdings plc - ADR
IMCR
|
BUY |
$72.00
Est. +115%
|
$33.44 | $39.33 |
Miss
|
$35.54
+6.3%
|
| Sep 11, 2024 |
Axsome Therapeutics Inc
AXSM
|
BUY |
$106.00
Est. +17%
|
$90.58 | $139.13 |
Target Met
|
$239.62
+164.5%
|
| Aug 21, 2024 |
Terns Pharmaceuticals Inc
TERN
|
BUY |
$10.00
Est. +28%
|
$7.79 | $11.40 |
Target Met
|
$52.95
+579.7%
|
| Aug 15, 2024 |
Insmed Inc
INSM
|
BUY |
$92.00
Est. +25%
|
$73.43 | $128.48 |
Target Met
|
$106.64
+45.2%
|
| Aug 08, 2024 |
Harmony Biosciences Holdings Inc
HRMY
|
BUY |
$42.00
Est. +25%
|
$33.55 | $41.61 |
Bullseye Hit (±1%)
|
$34.86
+3.9%
|
| Jul 29, 2024 |
Verastem Inc
VSTM
|
BUY |
$7.00
Est. +153%
|
$2.77 | $9.10 |
Target Met
|
$5.89
+112.6%
|
| Jul 08, 2024 |
Ideaya Biosciences Inc
IDYA
|
BUY |
$50.00
Est. +24%
|
$40.20 | $44.42 |
Miss
|
$35.00
-12.9%
|
| Jul 08, 2024 |
Neumora Therapeutics Inc.
NMRA
|
BUY |
$20.00
Est. +95%
|
$10.25 | $17.19 |
Miss
|
$1.54
-85.0%
|
| Jul 01, 2024 |
Apellis Pharmaceuticals Inc
APLS
|
BUY |
$49.00
Est. +28%
|
$38.36 | $42.47 |
Miss
|
$41.03
+7.0%
|
| Jun 20, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$100.00
Est. +31%
|
$76.06 | $131.98 |
Target Met
|
$131.87
+73.4%
|
| Jun 07, 2024 |
Insmed Inc
INSM
|
BUY |
$82.00
Est. +43%
|
$57.17 | $84.87 |
Target Met
|
$106.64
+86.5%
|
| May 17, 2024 |
Adaptimmune Therapeutics Plc - ADR
ADAP
|
BUY |
$3.00
Est. +150%
|
$1.20 | $1.48 |
Miss
|
$0.05
-96.0%
|
| May 16, 2024 |
Immatics N.V
IMTX
|
BUY |
$16.00
Est. +44%
|
$11.08 | $13.09 |
Miss
|
$9.17
-17.2%
|
| May 14, 2024 |
Amylyx Pharmaceuticals Inc
AMLX
|
BUY |
$3.00
Est. +65%
|
$1.82 | $7.26 |
Target Met
|
$17.70
+872.5%
|
| May 13, 2024 |
Immunocore Holdings plc - ADR
IMCR
|
BUY |
$88.00
Est. +54%
|
$57.25 | $41.53 |
Miss
|
$35.54
-37.9%
|
| May 13, 2024 |
Insmed Inc
INSM
|
BUY |
$36.00
Est. +42%
|
$25.33 | $84.87 |
Target Met
|
$106.64
+321.0%
|
| May 07, 2024 |
EyePoint Pharmaceuticals Inc
EYPT
|
BUY |
$30.00
Est. +168%
|
$11.20 | $13.99 |
Miss
|
$12.66
+13.0%
|
| Apr 02, 2024 |
Immuneering Corp - Ordinary Shares Class A
IMRX
|
BUY |
$8.00
Est. +191%
|
$2.75 | $3.83 |
Miss
|
$4.47
+62.5%
|
| Mar 28, 2024 |
Axsome Therapeutics Inc
AXSM
|
BUY |
$109.00
Est. +38%
|
$79.17 | $139.13 |
Target Met
|
$239.62
+202.7%
|
| Mar 17, 2024 |
Amylyx Pharmaceuticals Inc
AMLX
|
BUY |
$4.00
Est. +23%
|
$3.24 | $7.26 |
Target Met
|
$17.70
+446.3%
|
| Aug 15, 2023 |
BioXcel Therapeutics Inc
BTAI
|
BUY |
$4.00
Est. +1%
|
$3.98 | $89.92 |
Target Met
|
$0.88
-77.9%
|
| Aug 15, 2022 |
Cerevel Therapeutics Holdings Inc
CERE
|
SELL |
$27.00
Est. +23%
|
$34.86 | - | - |
$44.96
-29.0%
|
Amylyx Pharmaceuticals Inc
AMLX
Jul 20, 2026
Signal & Target
BUY
$24.00
Start Price
$17.75
Best Price (1Y)
$18.87
Current Price
$17.70
Return
-0.3%
Insmed Inc
INSM
Jun 16, 2026
Signal & Target
BUY
$192.00
Start Price
$97.46
Best Price (1Y)
$119.54
Current Price
$106.64
Return
+9.4%
Belite Bio Inc - ADR
BLTE
May 26, 2026
Signal & Target
BUY
$215.00
Start Price
$137.30
Best Price (1Y)
$161.43
Current Price
$157.14
Return
+14.5%
Corbus Pharmaceuticals Holdings Inc
CRBP
May 22, 2026
Signal & Target
BUY
$44.00
Start Price
$12.27
Best Price (1Y)
$12.88
Current Price
$8.84
Return
-28.0%
Amylyx Pharmaceuticals Inc
AMLX
Apr 28, 2026
Signal & Target
BUY
$21.00
Start Price
$16.88
Best Price (1Y)
$19.15
Current Price
$17.70
Return
+4.9%
Insmed Inc
INSM
Feb 19, 2026
Signal & Target
BUY
$211.00
Start Price
$151.11
Best Price (1Y)
$167.37
Current Price
$106.64
Return
-29.4%
Immatics N.V
IMTX
Feb 19, 2026
Signal & Target
BUY
$25.00
Start Price
$9.95
Best Price (1Y)
$11.94
Current Price
$9.17
Return
-7.8%
Belite Bio Inc - ADR
BLTE
Feb 19, 2026
Signal & Target
BUY
$223.00
Start Price
$173.91
Best Price (1Y)
$192.28
Current Price
$157.14
Return
-9.6%
Immix Biopharma Inc
IMMX
Feb 09, 2026
Signal & Target
BUY
$14.00
Start Price
$6.74
Best Price (1Y)
$12.14
Current Price
$9.41
Return
+39.6%
Corvus Pharmaceuticals Inc
CRVS
Jan 29, 2026
Signal & Target
BUY
$30.00
Start Price
$20.54
Best Price (1Y)
$22.34
Current Price
$13.99
Return
-31.9%
Neumora Therapeutics Inc.
NMRA
Jan 05, 2026
Signal & Target
BUY
$6.00
Start Price
$1.72
Best Price (1Y)
$3.65
Current Price
$1.54
Return
-10.5%
Axsome Therapeutics Inc
AXSM
Dec 31, 2025
Signal & Target
BUY
$217.00
Start Price
$182.86
Best Price (1Y)
$260.19
Current Price
$239.62
Return
+31.0%
Insmed Inc
INSM
Dec 18, 2025
Signal & Target
BUY
$212.00
Start Price
$167.71
Best Price (1Y)
$186.19
Current Price
$106.64
Return
-36.4%
Belite Bio Inc - ADR
BLTE
Dec 02, 2025
Signal & Target
BUY
$194.00
Start Price
$154.02
Best Price (1Y)
$192.94
Current Price
$157.14
Return
+2.0%
Insmed Inc
INSM
Dec 01, 2025
Signal & Target
BUY
$256.00
Start Price
$207.77
Best Price (1Y)
$212.75
Current Price
$106.64
Return
-48.7%
Terns Pharmaceuticals Inc
TERN
Nov 28, 2025
Signal & Target
BUY
$33.00
Start Price
$28.75
Best Price (1Y)
$53.18
Current Price
$52.95
Return
+84.2%
Apellis Pharmaceuticals Inc
APLS
Nov 03, 2025
Signal & Target
SELL
$19.00
Start Price
$21.47
Best Price (1Y)
$16.83
Current Price
$41.03
Return
-91.1%
Insmed Inc
INSM
Oct 29, 2025
Signal & Target
BUY
$196.00
Start Price
$166.97
Best Price (1Y)
$212.75
Current Price
$106.64
Return
-36.1%
Immatics N.V
IMTX
Oct 29, 2025
Signal & Target
BUY
$19.00
Start Price
$10.36
Best Price (1Y)
$12.40
Current Price
$9.17
Return
-11.5%
EyePoint Pharmaceuticals Inc
EYPT
Oct 29, 2025
Signal & Target
BUY
$33.00
Start Price
$12.25
Best Price (1Y)
$19.01
Current Price
$12.66
Return
+3.3%
Terns Pharmaceuticals Inc
TERN
Oct 22, 2025
Signal & Target
BUY
$9.00
Start Price
$8.12
Best Price (1Y)
$53.18
Current Price
$52.95
Return
+552.1%
Verastem Inc
VSTM
Oct 21, 2025
Signal & Target
BUY
$14.00
Start Price
$8.12
Best Price (1Y)
$10.83
Current Price
$5.89
Return
-27.5%
EyePoint Pharmaceuticals Inc
EYPT
Oct 20, 2025
Signal & Target
BUY
$28.00
Start Price
$11.63
Best Price (1Y)
$19.01
Current Price
$12.66
Return
+8.9%
Athira Pharma Inc
ATHA
Sep 19, 2025
Signal & Target
BUY
$4.00
Start Price
$3.83
Best Price (1Y)
$8.35
Current Price
$6.75
Return
+76.2%
Corvus Pharmaceuticals Inc
CRVS
May 20, 2025
Signal & Target
BUY
$11.00
Start Price
$3.68
Best Price (1Y)
$26.95
Current Price
$13.99
Return
+280.2%
Axsome Therapeutics Inc
AXSM
Mar 27, 2025
Signal & Target
BUY
$216.00
Start Price
$121.77
Best Price (1Y)
$191.50
Current Price
$239.62
Return
+96.8%
Axsome Therapeutics Inc
AXSM
Feb 03, 2025
Signal & Target
BUY
$137.00
Start Price
$107.43
Best Price (1Y)
$191.50
Current Price
$239.62
Return
+123.0%
Autolus Therapeutics plc - ADR
AUTL
Nov 18, 2024
Signal & Target
BUY
$7.60
Start Price
$3.03
Best Price (1Y)
$3.45
Current Price
$1.44
Return
-52.5%
Corvus Pharmaceuticals Inc
CRVS
Oct 22, 2024
Signal & Target
BUY
$12.00
Start Price
$7.56
Best Price (1Y)
$10.00
Current Price
$13.99
Return
+85.1%
Harmony Biosciences Holdings Inc
HRMY
Oct 10, 2024
Signal & Target
BUY
$52.00
Start Price
$33.60
Best Price (1Y)
$41.61
Current Price
$34.86
Return
+3.7%
Ideaya Biosciences Inc
IDYA
Sep 25, 2024
Signal & Target
BUY
$55.00
Start Price
$31.37
Best Price (1Y)
$32.67
Current Price
$35.00
Return
+11.6%
BioXcel Therapeutics Inc
BTAI
Sep 23, 2024
Signal & Target
BUY
$1.00
Start Price
$0.59
Best Price (1Y)
$13.28
Current Price
$0.88
Return
+49.1%
Apellis Pharmaceuticals Inc
APLS
Sep 20, 2024
Signal & Target
BUY
$39.00
Start Price
$36.73
Best Price (1Y)
$35.72
Current Price
$41.03
Return
+11.7%
Adverum Biotechnologies Inc
ADVM
Sep 20, 2024
Signal & Target
BUY
$20.00
Start Price
$7.50
Best Price (1Y)
$8.56
Current Price
$4.36
Return
-41.9%
Apellis Pharmaceuticals Inc
APLS
Sep 16, 2024
Signal & Target
BUY
$42.00
Start Price
$37.62
Best Price (1Y)
$37.84
Current Price
$41.03
Return
+9.1%
Corbus Pharmaceuticals Holdings Inc
CRBP
Sep 13, 2024
Signal & Target
BUY
$74.00
Start Price
$51.58
Best Price (1Y)
$56.93
Current Price
$8.84
Return
-82.9%
Immunocore Holdings plc - ADR
IMCR
Sep 12, 2024
Signal & Target
BUY
$72.00
Start Price
$33.44
Best Price (1Y)
$39.33
Current Price
$35.54
Return
+6.3%
Axsome Therapeutics Inc
AXSM
Sep 11, 2024
Signal & Target
BUY
$106.00
Start Price
$90.58
Best Price (1Y)
$139.13
Current Price
$239.62
Return
+164.5%
Terns Pharmaceuticals Inc
TERN
Aug 21, 2024
Signal & Target
BUY
$10.00
Start Price
$7.79
Best Price (1Y)
$11.40
Current Price
$52.95
Return
+579.7%
Insmed Inc
INSM
Aug 15, 2024
Signal & Target
BUY
$92.00
Start Price
$73.43
Best Price (1Y)
$128.48
Current Price
$106.64
Return
+45.2%
Harmony Biosciences Holdings Inc
HRMY
Aug 08, 2024
Signal & Target
BUY
$42.00
Start Price
$33.55
Best Price (1Y)
$41.61
Current Price
$34.86
Return
+3.9%
Verastem Inc
VSTM
Jul 29, 2024
Signal & Target
BUY
$7.00
Start Price
$2.77
Best Price (1Y)
$9.10
Current Price
$5.89
Return
+112.6%
Ideaya Biosciences Inc
IDYA
Jul 08, 2024
Signal & Target
BUY
$50.00
Start Price
$40.20
Best Price (1Y)
$44.42
Current Price
$35.00
Return
-12.9%
Neumora Therapeutics Inc.
NMRA
Jul 08, 2024
Signal & Target
BUY
$20.00
Start Price
$10.25
Best Price (1Y)
$17.19
Current Price
$1.54
Return
-85.0%
Apellis Pharmaceuticals Inc
APLS
Jul 01, 2024
Signal & Target
BUY
$49.00
Start Price
$38.36
Best Price (1Y)
$42.47
Current Price
$41.03
Return
+7.0%
Intra-Cellular Therapies Inc
ITCI
Jun 20, 2024
Signal & Target
BUY
$100.00
Start Price
$76.06
Best Price (1Y)
$131.98
Current Price
$131.87
Return
+73.4%
Insmed Inc
INSM
Jun 07, 2024
Signal & Target
BUY
$82.00
Start Price
$57.17
Best Price (1Y)
$84.87
Current Price
$106.64
Return
+86.5%
Adaptimmune Therapeutics Plc - ADR
ADAP
May 17, 2024
Signal & Target
BUY
$3.00
Start Price
$1.20
Best Price (1Y)
$1.48
Current Price
$0.05
Return
-96.0%
Immatics N.V
IMTX
May 16, 2024
Signal & Target
BUY
$16.00
Start Price
$11.08
Best Price (1Y)
$13.09
Current Price
$9.17
Return
-17.2%
Amylyx Pharmaceuticals Inc
AMLX
May 14, 2024
Signal & Target
BUY
$3.00
Start Price
$1.82
Best Price (1Y)
$7.26
Current Price
$17.70
Return
+872.5%
Immunocore Holdings plc - ADR
IMCR
May 13, 2024
Signal & Target
BUY
$88.00
Start Price
$57.25
Best Price (1Y)
$41.53
Current Price
$35.54
Return
-37.9%
Insmed Inc
INSM
May 13, 2024
Signal & Target
BUY
$36.00
Start Price
$25.33
Best Price (1Y)
$84.87
Current Price
$106.64
Return
+321.0%
EyePoint Pharmaceuticals Inc
EYPT
May 07, 2024
Signal & Target
BUY
$30.00
Start Price
$11.20
Best Price (1Y)
$13.99
Current Price
$12.66
Return
+13.0%
Immuneering Corp - Ordinary Shares Class A
IMRX
Apr 02, 2024
Signal & Target
BUY
$8.00
Start Price
$2.75
Best Price (1Y)
$3.83
Current Price
$4.47
Return
+62.5%
Axsome Therapeutics Inc
AXSM
Mar 28, 2024
Signal & Target
BUY
$109.00
Start Price
$79.17
Best Price (1Y)
$139.13
Current Price
$239.62
Return
+202.7%
Amylyx Pharmaceuticals Inc
AMLX
Mar 17, 2024
Signal & Target
BUY
$4.00
Start Price
$3.24
Best Price (1Y)
$7.26
Current Price
$17.70
Return
+446.3%
BioXcel Therapeutics Inc
BTAI
Aug 15, 2023
Signal & Target
BUY
$4.00
Start Price
$3.98
Best Price (1Y)
$89.92
Current Price
$0.88
Return
-77.9%
Cerevel Therapeutics Holdings Inc
CERE
Aug 15, 2022
Signal & Target
SELL
$27.00
Start Price
$34.86
Best Price (1Y)
-
Current Price
$44.96
Return
-29.0%